There are 1076 resources available
Rare targets and comprehensive genome profiling
Presenter: Angela Lamarca
Session: Personalising gastrointestinal (GI) oncology: From old to new target inhibition
Resources:
Slides
Webcast
Artificial intelligence (AI): Shaping the future of drug development
Presenter: Udai Banerji
Session: Latest advances/controversies in drug development
Resources:
Slides
Webcast
Challenges of equitable drug access: The WHO Essential Diagnostics List (EDL) for all or high-end molecules for few?
Presenter: Dario Trapani
Session: Cancer in low- or middle-income countries (LMICs): Challenges to prevention and providing equitable care
Resources:
Slides
Webcast
Invited Discussant 526MO, 463MO and 464MO
Presenter: Stein Kaasa
Session: Mini oral session: Supportive and palliative care
Resources:
Slides
Webcast
Q&A and discussion
Session: Mini Oral session: Thoracic malignancies
Resources:
Webcast
Q&A and discussion
Session: Personalising gastrointestinal (GI) oncology: From old to new target inhibition
Resources:
Webcast
Q&A and discussion
Session: Session in collaboration with AACR - Walkthroughs in clinical trials in the era of molecular oncology
Resources:
Webcast
Q&A and discussion
Session: Latest advances/controversies in drug development
Resources:
Webcast
Q&A and discussion
Session: Cancer in low- or middle-income countries (LMICs): Challenges to prevention and providing equitable care
Resources:
Webcast
614MO - A phase II study of Becotatug (JMT101) in combination with osimertinib (Osi) in patients (pts) with classical EGFR-mutated non-small cell lung cancer (NSCLC) (BOOSTER Study)
Presenter: Li Zhang
Session: Mini Oral session: Thoracic malignancies
Resources:
Abstract
Slides
Webcast